8-812.0:
Transfusion of plasma, plasma components and infusion of volume replacement fluids: Transfusion of plasma and other plasma components and genetically engineered plasma proteins: Alfa‑1-proteinase inhibitor human, parenteral
- 8-812.00 600 mg up to 1,200 mg
- 8-812.01 1,200 mg up to 1,800 mg
- 8-812.02 1,800 mg up to 2,400 mg
- 8-812.03 2,400 mg up to 3,000 mg
- 8-812.04 3,000 mg up to 3,600 mg
- 8-812.05 3,600 mg up to 4,200 mg
- 8-812.06 4,200 mg up to 4,800 mg
- 8-812.07 4,800 mg up to 5,400 mg
- 8-812.08 5,400 mg up to 6,000 mg
- 8-812.09 6,000 mg up to 7,200 mg
- 8-812.0a 7,200 mg up to 8,400 mg
- 8-812.0b 8,400 mg up to 9,600 mg
- 8-812.0c 9,600 mg up to 10,800 mg
- 8-812.0d 10,800 mg up to 13,200 mg
- 8-812.0e 13,200 mg up to 15,600 mg
- 8-812.0f 15,600 mg up to 18,000 mg
- 8-812.0g 18,000 mg up to 20,400 mg
- 8-812.0h 20,400 mg up to 22,800 mg
- 8-812.0j 22,800 mg up to 25,200 mg
- 8-812.0k 25,200 mg up to 27,600 mg
- 8-812.0m 27,600 mg up to 30,000 mg
- 8-812.0n 30,000 mg up to 34,800 mg
- 8-812.0p 34,800 mg up to 39,600 mg
- 8-812.0q 39,600 mg or more
Source
Provided by the non-profit organization “Was hab’ ich?” gemeinnützige GmbH on behalf of the Federal Ministry of Health (BMG).